Marksans Pharma is a finished-dose manufacturer based in India. It appears in 132 regulatory filings across 4 regulators, without an active US DMF or CEP on file. Its filings concentrate with DAV (Vietnam), US FDA and DIGEMAPS (DO). Its GMP standing is certified by US FDA, EMA and MHRA (UK). Its most recent recorded inspection, by US FDA, closed on 7 November 2025 as NAI. Customs aggregates show $139.0M of exports covering 4,709 molecules to 18 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Verna, India | 3023677905 |
| Verna, India | 3006230648 |
| Vasco Da Gama, India | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| DAV (Vietnam) | 74 | None |
| US FDA | 25 | 2 |
| DIGEMAPS (DO) | 20 | None |
| ARCSA (EC) | 13 | None |
| EMA | None | 1 |
| MHRA (UK) | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2025 | $301.0M | $139.0M | 18 |
| 2024 | $260.2M | $126.4M | 19 |
| 2023 | $224.3M | $91.3M | 24 |
| 2022 | Not reported | $85.9M | 21 |
Export figures are customs aggregates. We do not publish the identity of any buyer. Revenue shown in US dollars, converted from the reported currency.
Choose your molecules and target markets. Marksans Pharma comes back tiered against every other supplier able to file there.
Start for free